{"schema_version":"secwatch.filing_event.v1","accession":"0001641489-26-000012","form_type":"8-K","ticker":"VTVT","cik":"0001641489","company_name":"vTv Therapeutics Inc.","filed_at":"2026-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.725601+00:00","generated_at":"2026-05-15T16:42:13.181397+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"vTv Therapeutics posts updated investor presentation focused on diabetes pipeline","bullets":["Slide deck titled 'Committed to Improving the Lives of People with Diabetes' posted for March 2026.","Presentation will be used in meetings with investors, analysts, and other parties.","Filing notes the presentation may be amended or updated via future disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001641489-26-000012","json":"https://secwatch.observer/filing/0001641489-26-000012.json","markdown":"https://secwatch.observer/filing/0001641489-26-000012.md","text":"https://secwatch.observer/filing/0001641489-26-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641489/000164148926000012/0001641489-26-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641489/000164148926000012/vtvt-20260310.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T16:42:13.181397+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}